Data from a study into a potential blood test for breast cancer is "encouraging" as it would make early detection of the disease in all women much easier, a science chief has said.
Lead researcher on the study, Professor Martin Widschwendter, from University College London, said:
We identified an epigenetic signature in women with a mutated BRCA1 gene that was linked to increased cancer risk and lower survival rates.
Surprisingly, we found the same signature in large cohorts of women without the BRCA1 mutation and it was able to predict breast cancer risk several years before diagnosis.
The data is encouraging since it shows the potential of a blood-based epigenetic test to identify breast cancer risk in women without known predisposing genetic mutations.
More top news
Five men have been arrested on suspicion of terrorism offences in the West Midlands.caution
Consumers have been warned to immediately stop using Indesit tumble dryers after a machine reportedly caused a huge fire in a tower block.
Some 29 children have been killed in Aleppo in the week leading up to US-Russia talks which aid workers hope will lead to a vital ceasefire.